title: Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter.
authors.affiliation: Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: kim.dao@chuv.ch.
authors.forename: Kim
authors.initials: K
authors.lastname: Dao
authors.affiliation: Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
authors.forename: Haithem
authors.initials: H
authors.lastname: Chtioui
authors.affiliation: Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
authors.forename: Yimin
authors.initials: Y
authors.lastname: Lu
authors.affiliation: National Cancer Institute, Bethesda, Maryland.
authors.forename: Cody J
authors.initials: CJ
authors.lastname: Peer
authors.affiliation: National Cancer Institute, Bethesda, Maryland.
authors.forename: William D
authors.initials: WD
authors.lastname: Figg
authors.affiliation: Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
authors.forename: Menno
authors.initials: M
authors.lastname: Pruijm
authors.affiliation: Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
authors.forename: Thierry
authors.initials: T
authors.lastname: Buclin
authors.affiliation: Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Kissling
mesh_terms: D004867:Equipment Design; D006801:Humans; D007155:Immunologic Factors / Q000493:pharmacokinetics; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D009101:Multiple Myeloma / Q000378:metabolism / Q000628:therapy*; D006435:Renal Dialysis / Q000295:instrumentation*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D007155:Immunologic Factors; D008567:Membranes, Artificial; D013792:Thalidomide; C467566:pomalidomide